(888) 277-4253

PRESS RELEASE: Bonnie Dumanis issues statement on Merck investment in La Jolla

(Editor’s note: SDGLN is not reporting on the 2012 San Diego mayoral race because SDGLN Publisher Johnathan Hale has a personal relationship with City Councilmember Carl DeMaio, who is running for mayor. SDGLN will also not be making an endorsement in the race.

For the first time in San Diego history, the mayoral race has two prominent LGBT candidates: DeMaio and District Attorney Bonnie Dumanis. Although SDGLN will not be reporting on the mayoral race, we will, as a service to the LGBT community, publish selected press releases by DeMaio and Dumanis to inform our readers about their campaigns. These press releases will be clearly labeled as such so that readers understand they are not written by SDGLN staff members.

In addition, all candidates for any political race are allowed to submit two pieces per month for our Commentary page. SDGLN Editor in Chief Ken Williams can be reached at ken@sdgln.com, @KenSanDiego on Twitter or at (877) 727-5446, x713.)

THIS IS A PRESS RELEASE FROM THE BONNIE DUMANIS CAMPAIGN

SAN DIEGO – District Attorney and San Diego Mayoral candidate Bonnie Dumanis today released the following statement in response to the announcement Merck will invest up to $90 million in a La Jolla-based institute to identify new ways to fight disease.

“I’m encouraged by Merck’s decision to invest in the California Institute for Biomedical Research in La Jolla. This investment, and jobs it will bring, highlights the importance of synergy in our health care, biotech, research and university sectors. As Mayor, I plan to further leverage these synergies through a new Core Industries Task Force to further promote San Diego’s leadership position in these key sectors.”